In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

NEW YORK - Sally Susman, Pfizer's executive VP and chief corporate affairs officer, will depart the pharmaceutical giant at ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.

According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

Geopolitical risks can significantly reshape market access, disrupt operations, and drive costs up overnight. For businesses ...

DD’s Ortenca Aliaj and the FT’s Jim Pickard first reported on Tuesday that Sunak is set to join Goldman Sachs as a senior adviser, where he’ll work with its executives to advise clients on ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Susman is exiting her role as Pfizer’s top comms executive at the end of this year. The skincare brand is calling upon its community of dermatologists to spark a skin health movement.

Xaira Therapeutics named Jeff Jonker as president and chief operating officer. Norstella appointed Kris Joshi as its CEO. ABS Bio added Ehab Alramahy as president and CEO. Radiant Biotherapeutics ...